← Eichor
Study identifier: NCT06922786 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hemadsorption to Enhance Drug Elimination in Intoxications

Condition: Intoxication by Drug  ·  Sponsor: Universitair Ziekenhuis Brussel

PhaseNA
Planned participants18
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this trial the investigators assess the effectiveness of applying a hemadsorber (cytosorb®) in removing benzodiazepines or tricyclic antidepressants in intoxicated patients admitted to ICU with prolonged impaired consciousness. This is a one arm interventional investigation where a hemadsorption filter is applied in patients fulfilling inclusion criteria 8 hours after admission. Plasma titer of the neurodepressing drug will be collected sequentially both before and after start of hemadsorption to evaluate the speed of drug elimination before and after application of a hemadsorption filter. Pre- and post filter titers will be obtained to evaluate adsorbability and to evaluate time to saturation of the filter.

This description comes directly from the study's public registry record.

Talk to the study team

Marie-Claire vanmalderen, Study coordinator  ·  0032 24 76 31 10  ·  Marieclaire.vanmalderen@uzbrussel.be

Merel Stevens, Study coordinator  ·  0032 24 76 30 96  ·  Merel.stevens@uzbrussel.be

Always discuss trial participation with your own doctor first.

Locations (1)

Universitair Ziekenhuis BrusselBrussels, Brussels Capital, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06922786